Skip to content

Evaluation of Salt Sensitivity in Young Adults

Evaluation of Salt Sensitivity in Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02588352
Enrollment
40
Registered
2015-10-27
Start date
2012-05-31
Completion date
2015-03-31
Last updated
2016-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The current prospective cross-sectional pilot study is proposed to determine a set of characteristic factors associated with salt sensitivity in young adults by measuring blood pressure, serum aldosterone levels, urine analysis, arterial pulse wave velocity and central arterial pressure in response to short term increases in salt intake.

Detailed description

Since salt sensitivity at an early age is associated with subsequent hypertension and an increase in mortality, intervention by lifestyle modification including the reduction of sodium intake could prevent subsequent increases in blood pressure and development of hypertension, cardiovascular disease and death. It would therefore be beneficial to have a simple method of identifying salt sensitive young adults so that risk factor modification can be achieved to prevent progression of the effects of hypertension on heart function. This study is a longitudinal pilot study to identify characteristics of salt sensitive young adults so that this population of people can be identified early on and appropriate lifestyle modifications can be made to prevent the subsequent progression of hypertension and cardiovascular disease. The study will be conducted at 2 visits separated by one week. At the first visit, eligible subjects will be asked to complete questionnaires regarding childhood and current sodium intake.Subjects will be asked about family history of hypertension and cardiovascular disease. Subjects will also undergo blood pressure measurement in both arm, and will provide a blood sample and spot urine sample. Subjects will then be asked to take salt pills 3 times a day for one week, and then return to the study center for a repeat of the above measurements.

Interventions

DIETARY_SUPPLEMENTSalt tablet

Subjects will be given salt tablets and instructed to take 4 grams of sale three times a day (total of 12 grams of salt/day) for one week

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Young adults age 21-30 * Able and willing to provide written informed consent

Exclusion criteria

* Any cardiovascular or other chronic health problem * Chronic medications besides oral contraceptive pills in women * BMI\>30kg/m2 * Blood pressure \>140/90 mmHg * Inability or unwillingness to adhere to study procedures

Design outcomes

Primary

MeasureTime frameDescription
Presence of salt sensitivityVisit 1 (One Week)Defined as an increase in mean arterial blood pressure greater than 5 mmHg

Secondary

MeasureTime frameDescription
Change in aldosterone levelBaseline to Visit 2 (One Week)change in serum aldosterone level
Change in augmentation index (%)Baseline to Visit 2 (One Week)Change in augmentation index determined by radial artery tonometry

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026